TRPC6 and psoriasis: As TRPC6 channel activation could partially overcome this Ca2+ entry defect in psoriasis keratinocytes, specific TRPC6 channel activators e.g. out of the phloroglucinol class may be potential new drug candidates for the topical treatment of psoriasis.